177 related articles for article (PubMed ID: 21884664)
1. [Antibiotics can ameliorate circulatory complications of liver cirrhosis].
Madsen BS; Schaffalitzky de Muckadell OB
Ugeskr Laeger; 2011 Aug; 173(35):2127-30. PubMed ID: 21884664
[TBL] [Abstract][Full Text] [Related]
2. Gut microflora in the pathogenesis of the complications of cirrhosis.
Garcia-Tsao G; Wiest R
Best Pract Res Clin Gastroenterol; 2004 Apr; 18(2):353-72. PubMed ID: 15123075
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide and the hyperdynamic circulation in cirrhosis: is there a role for selective intestinal decontamination?
Rasaratnam B; Connelly N; Chin-Dusting J
Clin Sci (Lond); 2004 Nov; 107(5):425-34. PubMed ID: 15270715
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic changes in portal hypertension: new insights in the pathogenesis and clinical implications.
Michielsen PP; Pelckmans PA
Acta Gastroenterol Belg; 1994; 57(2):194-205. PubMed ID: 8053307
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota-related complications in cirrhosis.
Gómez-Hurtado I; Such J; Sanz Y; Francés R
World J Gastroenterol; 2014 Nov; 20(42):15624-31. PubMed ID: 25400446
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of extrahepatic vasodilation in portal hypertension.
Hennenberg M; Trebicka J; Sauerbruch T; Heller J
Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
[TBL] [Abstract][Full Text] [Related]
7. Splanchnic and systemic vasodilatation: the patient.
Tsai MH
J Clin Gastroenterol; 2007; 41 Suppl 3():S266-71. PubMed ID: 17975476
[TBL] [Abstract][Full Text] [Related]
8. Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.
Bolognesi M; Di Pascoli M; Verardo A; Gatta A
World J Gastroenterol; 2014 Mar; 20(10):2555-63. PubMed ID: 24627591
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis.
Martin PY; Ginès P; Schrier RW
N Engl J Med; 1998 Aug; 339(8):533-41. PubMed ID: 9709047
[No Abstract] [Full Text] [Related]
10. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.
Fernández J; Navasa M; Garcia-Pagan JC; G-Abraldes J; Jiménez W; Bosch J; Arroyo V
J Hepatol; 2004 Sep; 41(3):384-90. PubMed ID: 15336440
[TBL] [Abstract][Full Text] [Related]
11. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis.
Møller S; Bendtsen F
Liver Int; 2018 Apr; 38(4):570-580. PubMed ID: 28921803
[TBL] [Abstract][Full Text] [Related]
12. The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension.
Iwakiri Y
J Clin Gastroenterol; 2007; 41 Suppl 3():S288-94. PubMed ID: 17975478
[TBL] [Abstract][Full Text] [Related]
13. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
Wiest R; Groszmann RJ
Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
[TBL] [Abstract][Full Text] [Related]
15. [The role of intestinal microflora in the development of complications of hepatic cirrhosis-associated portal hypertension].
Garbuzenko DV
Klin Med (Mosk); 2007; 85(8):15-9. PubMed ID: 17926483
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic alterations in liver cirrhosis.
La Villa G; Gentilini P
Mol Aspects Med; 2008; 29(1-2):112-8. PubMed ID: 18177931
[TBL] [Abstract][Full Text] [Related]
17. [Dexamethasone, an inhibitor of the expression of inducible nitric oxide synthase, does not modify the hyperdynamic state in cirrhotic rats].
Albornoz L; Bandi JC; de las Heras M; Mastai R
Medicina (B Aires); 2000; 60(4):477-81. PubMed ID: 11188955
[TBL] [Abstract][Full Text] [Related]
18. Bacterial infections, sepsis, and multiorgan failure in cirrhosis.
Tandon P; Garcia-Tsao G
Semin Liver Dis; 2008 Feb; 28(1):26-42. PubMed ID: 18293275
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic changes in splanchnic blood vessels in portal hypertension.
Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H
Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of portal hypertension.
Bosch J; Pizcueta P; Feu F; Fernández M; García-Pagán JC
Gastroenterol Clin North Am; 1992 Mar; 21(1):1-14. PubMed ID: 1568769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]